Grace Therapeutics Inc
For the period ended Sep 30, 2024. Filed Nov 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 13, 2024
GRCE$1.87+0.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
Balance Sheets
| September 30, 2024 | March 31, 2024 | |
|---|---|---|
| (Expressed in thousands except share data) | $ | $ |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | 15,155 | 23,005 |
| Short-term investments | 15 | — |
| Receivables | 415 | 722 |
| Prepaid expenses | 477 | 283 |
| Total current assets | 16,062 | 24,010 |
| Equipment, net | 21 | 24 |
| Intangible assets | 41,128 | 41,128 |
| Goodwill | 8,138 | 8,138 |
| Total assets | 65,349 | 73,300 |
| Liabilities and shareholders’ equity | ||
| Current liabilities: | ||
| Trade and other payables | 2,674 | 1,684 |
| Total current liabilities | 2,674 | 1,684 |
| Derivative warrant liabilities | 2,603 | 4,359 |
| Deferred tax liability | 3,938 | 5,514 |
| Total liabilities | 9,215 | 11,557 |
| Commitments and contingencies (Note 11) | ||
| Shareholders’ equity: | ||
| Class A common shares, no par value per share; unlimited shares authorized; 10,139,861 and 9,399,404 shares issued and outstanding as of September 30, 2024 and March 31, 2024, respectively | 261,038 | 261,038 |
| Class B, C, D and E common shares, no par value per share; unlimited shares authorized; none issued and outstanding | — | — |
| Additional paid-in capital | 18,302 | 17,862 |
| Accumulated other comprehensive loss | (6,038) | (6,038) |
| Accumulated deficit | (217,168) | (211,119) |
| Total shareholders’ equity | 56,134 | 61,743 |
| Total liabilities and shareholders’ equity | 65,349 | 73,300 |
Condensed ConsolidatedStatements ofLoss and Comprehensive Loss
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.